Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
-
Shares outstanding
-
125,610,040
-
Total 13F shares
-
91,341,313
-
Share change
-
+13,558,812
-
Total reported value
-
$865,955,709
-
Put/Call ratio
-
6.4%
-
Price per share
-
$9.53
-
Number of holders
-
115
-
Value change
-
+$119,981,356
-
Number of buys
-
58
-
Number of sells
-
62
Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) as of Q1 2025
As of 31 Mar 2025,
Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,341,313 shares.
The largest 10 holders included
Two Seas Capital LP, OAKTREE CAPITAL MANAGEMENT LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GOLDMAN SACHS GROUP INC, Madison Avenue Partners, LP, VANGUARD GROUP INC, Rubric Capital Management LP, UBS Group AG, MILLENNIUM MANAGEMENT LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.